FINWIRES · TerminalLIVE
FINWIRES

$AVAH

14 stories mentioning AVAHUpdated 20d ago

Every FINWIRES story that references AVAH, newest first.

What are analysts saying about AVAH?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on AVAH?

Wire

Aveanna Healthcare's Growth Trajectory Supported by Secular Tailwinds, RBC Says

Aveanna Healthcare Holdings (AVAH) is facing secular tailwinds that back its growth trajectory, as evidenced by the company's increased fiscal 2026 outlook, RBC Capital Markets said in a Friday note.The company's management reiterated its view that private duty nursing, or PDN, appears insulated from potential Medicaid budgetary pressures related to the One Big Beautiful Bill Act, according to the note.Aveanna is also positioned to benefit from the upcoming PDN rate increase in California, as the state's 2027 budget includes a major investment in pediatric private duty nursing rates effective Jan. 1, 2027, RBC said.The investment firm expects the company's private duty services volumes to accelerate in the second half of 2026 and increase materially in 2027.RBC also noted Aveanna's ongoing preferred payor momentum across all of its segments, with the number of preferred-payor agreements nearing or meeting its 2026 targets.RBC raised its price target on Aveanna Healthcare Holdings to $16 from $10, with an outperform rating.Price: $13.88, Change: $+0.72, Percent Change: +5.47%

$AVAH
Sectors

Sector Update: Healthcare Stocks Edge Higher Pre-Bell Friday

Healthcare stocks were edging higher pre-bell Friday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.1% and the iShares Biotechnology ETF (IBB) advancing by 0.6%.Arbutus Biopharma (ABUS) shares were up more than 9% after the clinical-stage company said it plans to launch a modified Dutch auction tender offer to repurchase up to $230 million of its common shares at between $5 and $5.75 per share in cash.Aveanna Healthcare Holdings (AVAH) said selling stockholders priced a secondary public offering of 15 million common shares at $11.75 per share. Aveanna Healthcare stock was down nearly 3% premarket.Werewolf Therapeutics (HOWL) and Ambros Therapeutics entered into an all-stock merger agreement to create a Nasdaq-listed biotech focused on developing neridronate for complex regional pain syndrome type 1, the companies said. Shares of Werewolf were up 146% pre-bell.

$ABUS$AVAH$HOWL$IBB$XLV
Commodities

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday as Bitcoin Moves Past $77,000

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was up 0.4% and the actively traded Invesco QQQ Trust (QQQ) was 0.7% higher in Friday's premarket activity as Bitcoin moved past $77,000 in one of its best weeks.US stock futures were also higher, with S&P 500 Index futures up 0.5%, Dow Jones Industrial Average futures advancing 0.6%, and Nasdaq futures gaining 0.8% before the start of regular trading.The S&P Global flash Composite Purchasing Managers' Index for August will be released at 9:45 am ET.In premarket activity, bitcoin was up by 5.5%. Among cryptocurrency ETFs, the cryptocurrency fund ProShares Bitcoin Strategy ETF (BITO) was 6% higher, Ether ETF (EETH) advanced 2.2%, and Bitcoin & Ether Market Cap Weight ETF (BETH) was 0.02% lower.Power Play:Health CareThe State Street Health Care Select Sector SPDR ETF (XLV) retreated 0.3%, the Vanguard Health Care Index Fund (VHT) was up 0.2%, while the iShares US Healthcare ETF (IYH) advanced 3.3%. The iShares Biotechnology ETF (IBB) was 0.6% higher.Aveanna Healthcare (AVAH) stock was down more than 3% premarket after the company said Thursday that selling stockholders priced a secondary public offering of 15 million common shares at $11.75 apiece.Winners and Losers:IndustrialThe State Street Industrial Select Sector SPDR ETF (XLI) advanced 0.9%, while the Vanguard Industrials Index Fund (VIS) was up 1.4%, and the iShares US Industrials ETF (IYJ) was flat.GE Vernova (GEV) stock was up nearly 2% before the opening bell after the company said it was selected by Quinbrook for the third stage of the Supernode battery energy storage project in Queensland, Australia, expanding its technology role across all three stages of the development.ConsumerThe State Street Consumer Staples Select Sector SPDR ETF (XLP) was up 0.2%, the Vanguard Consumer Staples Index Fund ETF Shares (VDC) gained 0.2%, and the iShares US Consumer Staples ETF (IYK) advanced 0.1%. The State Street Consumer Discretionary Select Sector SPDR ETF (XLY) increased 0.6%. The VanEck Retail ETF (RTH) was inactive, while the State Street SPDR S&P Retail ETF (XRT) was 0.9% higher.Tesla (TSLA) shares were up more than 1% pre-bell, following a 1.7% retreat in the previous session. China's State Administration for Market Regulation said the EV-maker is recalling more than 5.7 million vehicles in China over two separate safety issues involving emergency door handles and driver-attention monitoring.FinancialThe State Street Financial Select Sector SPDR ETF (XLF) advanced 0.5%. Direxion Daily Financial Bull 3X Shares (FAS) was up 1.2%, while its bearish counterpart, Direxion Daily Financial Bear 3X Shares (FAZ), was 1.2% lower.KKR (KKR), alongside Dragoneer Investment Group (DGNR) and insurance distributor Amwins, has agreed to acquire Steadfast Group in a deal worth approximately 7.7 billion Australian dollars ($5.52 billion). Shares of KKR were up more than 1% premarket.TechnologyThe State Street Technology Select Sector SPDR ETF (XLK) advanced 0.8%, the iShares US Technology ETF (IYW) was 0.9% higher, and the iShares Expanded Tech Sector ETF (IGM) was up 0.4%. Among semiconductor ETFs, the State Street SPDR S&P Semiconductor ETF (XSD) increased 1.3%, while the iShares Semiconductor ETF (SOXX) rose by 1.6%.Broadcom (AVGO) shares were up more than 1% in premarket activity after Bloomberg News reported late Thursday that the company is in discussions with a group of lenders to raise as much as $100 billion in debt for an artificial intelligence chip financing deal.EnergyThe iShares US Energy ETF (IYE) gained 0.8%, while the State Street Energy Select Sector SPDR ETF (XLE) was up by 0.1%.Vistra (VST) stock was up more than 1% before market open after Morgan Stanley lifted its price target to $227 from $212.CommoditiesFront-month US West Texas Intermediate crude oil gained by 0.2% to reach $86.99 per barrel on the New York Mercantile Exchange. Natural gas was up 1% at $2.76 per 1 million British Thermal Units. The United States Oil Fund (USO) increased 0.6%, while the United States Natural Gas Fund (UNG) was 0.6% higher.Gold futures for November advanced by 1.3% to $4,628.70 an ounce on the Comex. Silver futures rose 1.8% to $70.14 an ounce. SPDR Gold Shares (GLD) gained 1.1%, and the iShares Silver Trust (SLV) was 1.7% higher.

Dow JonesNasdaq CompositeS&P 500$AVAH$AVGO$BETH$BITO$DGNR$EEM$EETH$EXI$FAS$FAZ$GEV$GLD$IBB$IGM$IGV$IPK$IVV$IWM$IYE$IYH$IYJ$IYK$IYW$KKR$PMR$QQQ$RTH$SLV$SOXX$SPY$TSLA$UNG$USO$VDC$VHT$VIS$VST$XLE$XLF$XLI$XLK$XLP$XLV$XLY$XRT$XSD
Wire

Update: Aveanna Healthcare Shares Rise After Fiscal Q2 Beat

(Updates with the latest stock price movement in the headline and the first paragraph.)Aveanna Healthcare (AVAH) shares rose more than 20% on Thursday after the company reported better-than-expected fiscal Q2 results.The company reported fiscal Q2 adjusted earnings Thursday of $0.22 per diluted share, up from $0.18 a year earlier.Analysts polled by FactSet expected $0.17.Revenue for the quarter ended July 4 was $670.5 million, up from $589.6 million a year earlier.Analysts projected $638.6 million.The company said it now expects full-year 2026 revenue greater than $2.68 billion, compared with a prior estimate of $2.63 billion to $2.65 billion. Analysts forecast $2.63 billion.Price: $10.88, Change: $+1.83, Percent Change: +20.22%

$AVAH
Insider Trading

Aveanna Healthcare Holdings Insider Sold Shares Worth $43,680,000, According to a Recent SEC Filing

Robert M Williams Jr, 10% Owner, on June 03, 2026, sold 7,000,000 shares in Aveanna Healthcare Holdings (AVAH) for $43,680,000. Following the Form 4 filing with the SEC, Williams has control over a total of 33,065,892 common shares of the company, with 33,065,892 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1832332/000119312526258798/xslF345X05/ownership.xmlPrice: $6.68, Change: $+0.05, Percent Change: +0.75%

$AVAH
Insider Trading

Aveanna Healthcare Holdings Insider Sold Shares Worth $43,680,000, According to a Recent SEC Filing

Paul R Vigano, 10% Owner, on June 03, 2026, sold 7,000,000 shares in Aveanna Healthcare Holdings (AVAH) for $43,680,000. Following the Form 4 filing with the SEC, Vigano has control over a total of 33,065,892 common shares of the company, with 33,065,892 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1832332/000119312526258806/xslF345X05/ownership.xmlPrice: $6.67, Change: $+0.04, Percent Change: +0.53%

$AVAH
Wire

Aveanna Healthcare's Preferred Payor Relationships Buffer Medicaid Pressures, RBC Says

Aveanna Healthcare's (AVAH) growing market presence and steady improvement in preferred payor mix create a natural buffer against potential Medicaid budgetary pressures, RBC Capital Markets said Wednesday.The company's growing concentration of preferred payor clients shifts its volume toward managed care organizations that value and differentially reimburse private duty nursing services to reduce total healthcare spend, according to the note.RBC said it believes preferred payor relationships largely insulate Aveanna's PDN platform from state budget constraints, especially as payors seek to expand access to higher quality care in lower cost settings. The brokerage added that the recently completed Family First acquisition enhances the company's scale and market density.The company presents a strong value proposition for Medicaid managed care payors that seems to be underappreciated by the market, the brokerage said. The stock's recent pullback offers a compelling buying opportunity, it added.RBC upgraded Aveanna Healthcare to outperform from sector perform, while maintaining a price target of $10.Shares of Aveanna rose more than 6% in Wednesday trading.Price: $6.87, Change: $+0.40, Percent Change: +6.11%

$AVAH
Research

RBC Upgrades Aveanna Healthcare Holdings to Outperform From Sector Perform, Keeps $10 Price Target

Aveanna Healthcare Holdings (AVAH) has an average rating of overweight and mean price target of $10.05, according to analysts polled by FactSet.

$AVAH
Wire

Aveanna Healthcare Shares Rise After Stephens Upgrade

Aveanna Healthcare (AVAH) shares rose 4.1% on Friday after Stephens upgraded the stock to overweight from equalweight and adjusted its price target to $11 per share from $10.Trading volume stood at over 1.9 million shares compared with a daily average of more than 1.3 million.Price: $7.75, Change: $+0.31, Percent Change: +4.17%

$AVAH
Research

Stephens Upgrades Aveanna Healthcare to Overweight From Equalweight, Adjusts Price Target to $11 From $10

Aveanna Healthcare Holdings Inc (AVAH) has an average rating of overweight and mean price target of $9.80, according to analysts polled by FactSet.

$AVAH
Sectors

Sector Update: Healthcare Stocks Mixed Late Afternoon

Healthcare stocks were mixed late Thursday afternoon, with the NYSE Healthcare Index easing 0.1% and the State Street Healthcare Select Sector SPDR ETF (XLV) fractionally higher.The iShares Biotechnology ETF (IBB) decreased 0.7%.In corporate news, Prestige Consumer Healthcare's (PBH) officials said Thursday that weak eye care sales and a difficult consumer backdrop drove disappointing fiscal Q4 results at the consumer healthcare products company. Its shares were down past 11%.Biogen (BIIB) shares fell nearly 7% after the firm said Thursday that a phase 2 trial of diranersen in people with early Alzheimer's disease did not meet its primary endpoint.Doximity (DOCS) could face near-term pressure from slowing growth after issuing weaker-than-expected guidance, though strong user engagement trends and expanding AI opportunities continue to support the stock's long-term outlook, Morgan Stanley said in a note. Morgan Stanley lowered the price target on Doximity to $35 from $49, while maintaining an overweight rating. Doximity shares dropped more than 23%.Aveanna Healthcare (AVAH) shares jumped past 8% after it reported higher fiscal Q1 adjusted earnings and revenue, and raised its fiscal 2026 revenue guidance.

$AVAH$BIIB$DOCS$PBH
Sectors

Sector Update: Healthcare Stocks Softer Thursday Afternoon

Healthcare stocks edged down Thursday afternoon, with the NYSE Healthcare Index easing 0.1% and the State Street Healthcare Select Sector SPDR ETF (XLV) fractionally lower.The iShares Biotechnology ETF (IBB) decreased 0.5%.In corporate news, Biogen (BIIB) shares fell nearly 6% after the firm said Thursday that a phase 2 trial of diranersen in people with early Alzheimer's disease did not meet its primary endpoint.Prestige Consumer Healthcare (PBH) reported weaker-than-expected Q4 results and issued 2026 guidance below consensus, with the shortfall driven primarily by supply constraints in Clear Eyes and broader execution pressures, Oppenheimer said in a note. Oppenheimer downgraded the stock to perform from outperform and removed its $65 price target. Prestige shares slumped past 8%.Doximity (DOCS) could face near-term pressure from slowing growth after issuing weaker-than-expected guidance, though strong user engagement trends and expanding AI opportunities continue to support the stock's long-term outlook, Morgan Stanley said in a note. Morgan Stanley lowered the price target on Doximity to $35 from $49, while maintaining an overweight rating. Doximity shares dropped more than 24%.Aveanna Healthcare (AVAH) shares jumped 11% after it reported higher fiscal Q1 adjusted earnings and revenue, and raised its fiscal 2026 revenue guidance.

$AVAH$BIIB$DOCS$PBH
Sectors

Sector Update: Healthcare Stocks Mixed Premarket Thursday

Healthcare stocks were mixed premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.2% higher and the iShares Biotechnology ETF (IBB) declining by 0.1%.Aveanna Healthcare (AVAH) stock was up more than 9% after the company reported higher fiscal Q1 adjusted earnings and revenue, and raised its fiscal 2026 revenue guidance.Biogen (BIIB) shares were up more than 1% after the company said a phase 2 study evaluating diranersen in patients with early Alzheimer's disease did not meet its primary endpoint evaluating dose response for change from baseline on the Clinical Dementia Rating-Sum of Boxes at week 76.MeiraGTx (MGTX) stock was down 1% after the company posted a wider Q1 adjusted loss as revenue fell during the period.

$AVAH$BIIB$IBB$MGTX$XLV
Sectors

Sector Update: Healthcare

Healthcare stocks were mixed premarket Thursday, with the State Street Health Care Select Sector SPDR ETF (XLV) 0.1% higher and the iShares Biotechnology ETF (IBB) marginally declining.Aveanna Healthcare (AVAH) stock was up nearly 8% after the company reported higher fiscal Q1 adjusted earnings and revenue, and raised its fiscal 2026 revenue guidance.

$AVAH

Track with the FINWIRES app suite